Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.

Ali, Mohamed; Raslan, Mohamed; Ciebiera, Michal; Zareba, Kornelia; Al-Hendy, Ayman

Ali, Mohamed; Raslan, Mohamed; Ciebiera, Michal; Zareba, Kornelia; Al-Hendy, Ayman.

Afiliação

Ali M; Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Raslan M; Drug Research Center (Drc), Cairo, Egypt.
Ciebiera M; Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, Ceglowska, Warsaw, Poland.
Zareba K; First Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, Zelazna, Warsaw, Poland.
Al-Hendy A; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.

Expert Opin Drug Saf ; 21(4): 477-486, 2022 Apr.

Article em En | MEDLINE | ID: mdl-34612122

Assuntos

Hormônio Liberador de Gonadotropina/análogos & derivados; Leiomioma; Neoplasias Uterinas; Ácidos Carboxílicos/uso terapêutico; Feminino; Humanos; Leiomioma/tratamento farmacológico; Pirimidinas; Neoplasias Uterinas/tratamento farmacológico

Palavras-chave

GnRH analogs; add-back therapy; hypoestrogenic side effects; leiomyoma; safety; uterine fibroids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Hormônio Liberador de Gonadotropina / Leiomioma Limite: Female / Humans Idioma: En Revista: Expert Opin Drug Saf Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google